Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
clonal fetal mesenchymal stem cells
- Development stage
- Phase 2
- Lead developer
- Shenzhen Geno-Immune Medical Institute
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intraperitoneal, Intrathecal, Local Injection, Intramyocardial, Topical
01
Overview
Clonal fetal mesenchymal stem cells (cfMSCs) are an allogeneic cell therapy product consisting of mesenchymal stem cells derived from fetal tissue and expanded from a single-cell clone to ensure population homogeneity and consistent therapeutic potency. Developed by the Shenzhen Geno-Immune Medical Institute, these cells are designed to address severe symptoms of immune-related disorders, tissue damage, chronic obstructive pulmonary disease (COPD), and type II diabetes mellitus. The therapeutic mechanism of cfMSCs involves the secretion of anti-inflammatory cytokines and growth factors that modulate the host immune response and promote endogenous tissue repair and regeneration. By utilizing a clonal derivation process, the developer aims to overcome the variability and characterization challenges often associated with traditional, heterogeneous MSC preparations.
- Other names
- cfMSCsclonally derived fetal mesenchymal stem cells
Beyond the preview
Go deeper on clonal fetal mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on clonal fetal mesenchymal stem cells.